294 related articles for article (PubMed ID: 21514070)
1. Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma.
Wang H; Li YX; Wang WH; Jin J; Dai JR; Wang SL; Liu YP; Song YW; Wang ZY; Liu QF; Fang H; Qi SN; Liu XF; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1115-21. PubMed ID: 21514070
[TBL] [Abstract][Full Text] [Related]
2. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma.
Liu X; Huang E; Wang Y; He Y; Luo H; Zhong M; Qiu D; Li C; Yang H; He G; Zhou J; Jin F
Radiat Oncol; 2017 Apr; 12(1):76. PubMed ID: 28449713
[TBL] [Abstract][Full Text] [Related]
5. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma.
Li YX; Wang H; Jin J; Wang WH; Liu QF; Song YW; Wang ZY; Qi SN; Wang SL; Liu YP; Liu XF; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1809-15. PubMed ID: 21470789
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of skin toxicity in patients with extranodal nasal-type natural killer/T-cell lymphoma after treatment with intensity-modulated radiotherapy and conventional radiotherapy.
Gu Y; Yu H; Zuo X; Cao Q; Liang T; Ren Y; Yang H; Yang D
J Cancer Res Ther; 2018 Dec; 14(Supplement):S975-S979. PubMed ID: 30539832
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical results.
Shen Q; Ma X; Hu W; Chen L; Huang J; Guo Y
Radiat Oncol; 2013 Jun; 8():152. PubMed ID: 23800149
[TBL] [Abstract][Full Text] [Related]
10. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
Wang ZY; Li YX; Wang WH; Jin J; Wang H; Song YW; Liu QF; Wang SL; Liu YP; Qi SN; Fang H; Liu XF; Yu ZH
Blood; 2009 Nov; 114(23):4771-6. PubMed ID: 19812381
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.
Xu LM; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Liu QF; Chen B; Qi SN; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1289-95. PubMed ID: 23245279
[TBL] [Abstract][Full Text] [Related]
12. A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma.
Liu X; Yang Y; Jin F; He Y; Zhong M; Luo H; Qiu D; Li C; Yang H; He G; Wang Y
Med Dosim; 2016; 41(1):42-6. PubMed ID: 26428072
[TBL] [Abstract][Full Text] [Related]
13. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.
Yang CW; Wang CW; Hong RL; Tsai CL; Yao M; Tang JL; Lin CW; Cheng AL; Kuo SH
J Radiat Res; 2017 Jan; 58(1):114-122. PubMed ID: 27534792
[TBL] [Abstract][Full Text] [Related]
17. Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life.
Liu X; Fang H; Tian Y; Wang WH; Song YW; Wang SL; Liu YP; He XH; Dong M; Ren H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):712-20. PubMed ID: 27034178
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma.
Liu X; Wang Y; Guo Q; Luo H; Luo Q; Li Q; Wu Z; Jin F
Oncol Res Treat; 2020; 43(4):140-145. PubMed ID: 32018254
[TBL] [Abstract][Full Text] [Related]
19. [Long-term effect of risk-adaptive therapy for early stage extranodal NK/T cell lymphoma].
Wu T; Liu QL; Hu YF; Zhang J; Chen MX; Chen XX; Huang YH; Lu B
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):859-864. PubMed ID: 31770855
[No Abstract] [Full Text] [Related]
20. Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy.
Li YX; Liu QF; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Liu XF; Zhou LQ; Yu ZH
Cancer; 2011 Nov; 117(22):5203-11. PubMed ID: 21523771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
